One year in review; Authors: Alessandra Bortoluzzi, Federica Furini, Elena Generali, Ettore Silvagni, Nicoletta Luciano, Carlo Alberto Scirè

clinexprheumatol.org


Mavrilimumab well tolerated among patients with RA

Mavrilimumab treatment for more than 3 years maintained response and…
healio.com

Since the introduction of TNF-α inhibitors and other biologic agents, the clinical outcome for many treated rheumatoid arthritis patients has signific…

sciencedirect.com


nature.com